MJ Calasanz

Full Professor of Genetics

Universidad de Navarra

Spain

Research Interests

Explore related searches

Professors in Spain Professors in Cancer Biology Cancer Biology professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

MJ Calasanz is a Full Professor of Genetics at Universidad de Navarra, Spain. His research focuses on genomics and its application in hematological malignancies, particularly in acute myeloid leukemia and multiple myeloma. Recent publications include studies on genomic classification, machine learning for risk stratification, and the role of long noncoding RNAs in cancer outcomes.

Articles (10)

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (19)

Cristina Jiménez

SPAIN

MJ Calasanz

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Molecular Landscape and Validation of New Genomic Classification in 2668 Adult AML Patients: Real Life Data from the PETHEMA Registry

Unsupervised machine learning improves risk stratification in newly diagnosed multiple myeloma: an analysis of the Spanish Myeloma Group

<i>TP53</i> Abnormalities Are Underlying the Poor Outcome Associated with Chromothripsis in Chronic Lymphocytic Leukemia Patients with Complex Karyotype

NGS-Based Molecular Karyotyping of Multiple Myeloma: Results from the GEM12 Clinical Trial

Preneoplastic somatic mutations including MYD88 L265P in lymphoplasmacytic lymphoma

Landscape and clinical significance of long noncoding RNAs involved in multiple myeloma expressed fusion transcripts

Characteristics and Outcomes of Adult Patients in the PETHEMA Registry with Relapsed or Refractory <i>FLT3</i>-ITD Mutation-Positive Acute Myeloid Leukemia

Circulating Tumor Cells for the Staging of Patients With Newly Diagnosed Transplant-Eligible Multiple Myeloma.

A Machine Learning Model Based on Tumor and Immune Biomarkers to Predict Undetectable MRD and Survival Outcomes in Multiple Myeloma.

Characterization of complete lncRNAs transcriptome reveals the functional and clinical impact of lncRNAs in multiple myeloma.

Collaborators (19)

Cristina Jiménez

ROSA MARIA AYALA DIAZ

Felipe de Arriba de la Fuente

Gian Matteo Rigolin

Luis Vitores Valcárcel

Iria Vázquez Urio

Rebeca Rodríguez-Veiga

María-Belén Vidriales

Juan Manuel Alonso-Dominguez

Victor Segura

Miguel Sanz

Cristina Pérez Ruiz

Raquel Ordonez

Florence Nguyen-Khac

Cirino Botta

Jose A Martinez-Climent

Professor Jonathan C Strefford

Albert Oriol

Norma C. Gutiérrez

Make your next move.